Translating efficacy of liver transplantation in liver-limited metastatic colorectal cancer into clinical practice: the TransMet trial
-
Published:2024-09
Issue:9
Volume:9
Page:103669
-
ISSN:2059-7029
-
Container-title:ESMO Open
-
language:en
-
Short-container-title:ESMO Open
Author:
Germani M.M.ORCID,
Raschzok N.,
Heinemann V.,
Modest D.P.ORCID
Reference19 articles.
1. Metastatic colorectal cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up;Cervantes;Ann Oncol,2023
2. First-line systemic treatment strategies in patients with initially unresectable colorectal cancer liver metastases (CAIRO5): an open-label, multicentre, randomised, controlled, phase 3 study from the Dutch Colorectal Cancer Group;Bond;Lancet Oncol,2023
3. Liver transplantation for non-resectable colorectal liver metastases: the International Hepato-Pancreato-Biliary Association consensus guidelines;Bonney;Lancet Gastroenterol Hepatol,2021
4. Transplantation for nonresectable colorectal liver metastases: long-term follow-up of the first prospective pilot study;Solheim;Ann Surg,2023
5. Survival following liver transplantation for patients with nonresectable liver-only colorectal metastases;Dueland;Ann Surg,2020